This company has been marked as potentially delisted and may not be actively trading. Alpine Immune Sciences (ALPN) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock ALPN Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Alpine Immune Sciences Inc.January 10, 2025 | thestreet.comFrazier Life Sciences Appoints Biotech Innovators Mitchell H. Gold and Stanford L. Peng as Venture PartnersJanuary 9, 2025 | finance.yahoo.comBNP Paribas Financial Markets Buys 93,423 Shares of Alpine Immune Sciences, Inc. (NASDAQ:ALPN)May 25, 2024 | marketbeat.comAlpine Immune Sciences (NASDAQ:ALPN) Reaches New 12-Month High at $65.00May 20, 2024 | marketbeat.comJump Financial LLC Buys Shares of 55,720 Alpine Immune Sciences, Inc. (NASDAQ:ALPN)May 18, 2024 | marketbeat.comWhat 11 Analyst Ratings Have To Say About Alpine Immune SciencesMay 16, 2024 | markets.businessinsider.comAlpine Immune Sciences (NASDAQ:ALPN) Given "Neutral" Rating at WedbushMay 16, 2024 | marketbeat.comAlpine Immune Sciences, Inc. (NASDAQ:ALPN) Receives Consensus Recommendation of "Hold" from AnalystsMay 16, 2024 | marketbeat.comAlpine Immune Sciences (NASDAQ:ALPN) Reaches New 52-Week High at $64.96May 14, 2024 | marketbeat.comAlpine Immune Sciences, Inc. (NASDAQ:ALPN) Sees Significant Drop in Short InterestMay 13, 2024 | marketbeat.comAlpine Immune Sciences (NASDAQ:ALPN) Sees Large Volume IncreaseMay 10, 2024 | marketbeat.comALPN Stock Earnings: Alpine Immune Sciences Beats EPS, Beats Revenue for Q1 2024May 9, 2024 | investorplace.comAlpine Immune Sciences Reports First Quarter 2024 Financial ResultsMay 9, 2024 | businesswire.comAlpine Immune Sciences, Inc. (NASDAQ:ALPN) Shares Sold by Vivo Capital LLCMay 9, 2024 | marketbeat.comAlpine Immune Sciences (NASDAQ:ALPN) Sets New 52-Week High at $64.72May 8, 2024 | marketbeat.comVertex Pharmaceuticals Inc (VRTX) (Q1 2024) Earnings Call Transcript Highlights: Strong Growth ...May 7, 2024 | finance.yahoo.comAlpine Immune Sciences IncMay 1, 2024 | morningstar.comMAlpine Immune Sciences (NASDAQ:ALPN) Sets New 1-Year High at $64.70April 29, 2024 | marketbeat.comVivo Capital LLC Sells 298,770 Shares of Alpine Immune Sciences, Inc. (NASDAQ:ALPN)April 27, 2024 | marketbeat.comLatest News for Alpine Immune Sciences Stock (NASDAQ:ALPN)April 27, 2024 | benzinga.comALPINE IMMUNE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Alpine Immune ...April 27, 2024 | businesswire.comALPINE IMMUNE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Alpine Immune Sciences, Inc. - ALPNApril 26, 2024 | businesswire.comAlpine Immune Sciences, Inc. (ALPN)April 23, 2024 | finance.yahoo.comAlpine Immune Sciences (NASDAQ:ALPN) Sets New 1-Year High at $64.58April 22, 2024 | marketbeat.comTD Cowen Downgrades Alpine Immune Sciences (ALPN)April 18, 2024 | msn.comINVESTIGATION: The M&A Class Action Firm Announces an Investigation of Alpine Immune Sciences, Inc. - ALPNApril 17, 2024 | prnewswire.comAlpine Immune Sciences (ALPN) Price Target Increased by 36.91% to 63.24April 17, 2024 | msn.comAlpine Immune Sciences (NASDAQ:ALPN) Given "Hold" Rating at TD CowenApril 16, 2024 | marketbeat.comCan You Afford to Ignore These 3 Biotech Stocks Up Over 160% in 2024?April 15, 2024 | investorplace.comAlpine Immune Sciences, Inc. (NASDAQ:ALPN) Shares Bought by Vanguard Group Inc.April 15, 2024 | marketbeat.comAlpine Immune Sciences (NASDAQ:ALPN) Downgraded by Leerink Partnrs to Market PerformApril 13, 2024 | marketbeat.comCould This Stock Be the Next Biotech Buyout?April 13, 2024 | fool.comSHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Alpine Immune Sciences, Inc. BuyoutApril 12, 2024 | stockhouse.comALPINE IMMUNE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Alpine Immune Sciences, Inc. - ALPNApril 12, 2024 | businesswire.comAlpine Immune Sciences' (ALPN) "Market Perform" Rating Reaffirmed at SVB LeerinkApril 12, 2024 | marketbeat.comAlpine Immune Sciences (NASDAQ:ALPN) Downgraded by HC WainwrightApril 12, 2024 | marketbeat.comThese Stocks Moved the Most Today: CarMax, Apple, Fastenal, Rivian, Alpine Immune, Nike, Robinhood, Constellation Brands, and MoreApril 11, 2024 | finance.yahoo.comVertex To Buy Alpine Immune - Why This Deal Feels Slightly 'Vanilla'April 11, 2024 | seekingalpha.comVertex Pharmaceuticals to Buy Alpine Immune in $4.9B DealApril 11, 2024 | barrons.comAlpine Catapults 37% After Vertex Pledges $4.9 Billion To Buy ItApril 11, 2024 | investors.comThe $5 BILLION Reason Alpine Immune Sciences (ALPN) Stock Is Up 30% TodayApril 11, 2024 | investorplace.comAlpine Immune Sciences' (ALPN) "Neutral" Rating Reaffirmed at WedbushApril 11, 2024 | marketbeat.comAlpine Immune Sciences soars on $4.9bn Vertex takeoverApril 11, 2024 | proactiveinvestors.comVertex Stock in Focus After Deal to Buy Alpine Immune For $4.9B—Key Level to WatchApril 10, 2024 | investopedia.comShareholder Alert: Ademi LLP investigates whether Alpine Immune Sciences, Inc. has obtained a Fair Price in its transaction with VertexApril 10, 2024 | prnewswire.comALPN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Alpine Immune Sciences, Inc. Is Fair to ShareholdersApril 10, 2024 | businesswire.comVertex Pharmaceuticals Nabs Alpine Immune Sciences In $4.9 Billion DealApril 10, 2024 | investors.comVertex Pharmaceuticals to buy Alpine Immune Sciences for $4.9 blnApril 10, 2024 | reuters.comAlpine Immune Sciences (Nasdaq:ALPN) HeadlineTrading was temporarily halted for "ALPN" at 04:04 PM with a stated reason of "News pending."...April 10, 2024 | marketbeat.comAlpine Immune Is Weighing Options After Takeover InterestApril 10, 2024 | bloomberg.com Get Alpine Immune Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ALPN and its competitors with MarketBeat's FREE daily newsletter. Email Address ALPN Media Mentions By Week ALPN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ALPN News Sentiment▼0.001.00▲Average Medical News Sentiment ALPN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ALPN Articles This Week▼00▲ALPN Articles Average Week Get Alpine Immune Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ALPN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ITCI News MOR News CALT News ZYME News CMRX News CDMO News MBX News RVNC News CKPT News AVTE News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ALPN) was last updated on 7/12/2025 by MarketBeat.com Staff From Our PartnersI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alpine Immune Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alpine Immune Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ALPN Stock Alerts